Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 433-400-2 | CAS number: 4245-76-5
Endpoint summary
Administrative data
Description of key information
A No- Observable-Adverse-Effect Level (NOAEL) of 300 mg/kg body weight per day is defined for males and 1000 mg/kg body weight per day for females
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
Additional information
Oral administration of CA 2342 A to rats by daily gavage was well tolerated at all dose levels tested. In the absence of histopathologic correlates as well as supportive findings from organ weight analysis, the changes seen on some blood chemistry parameters (at dose levels of 100 mg/kg bw per day and above) point to influencing the renal function. In addition, adaptive changes of the liver were observed. Reversibility was demonstrated for all changes within a 4-week treatment free period except for calcium concentration in blood of males. Due to the irreversibility in males, a No- Observable-Adverse-Effect Level (NOAEL) of 300 mg/kg body weight per day is defined for males and 1000 mg/kg body weight per day for females.
Repeated dose toxicity: via oral route - systemic effects (target organ) urogenital: kidneys
Justification for classification or non-classification
For a classification as Category 2 STOT-RTD (specific target organ toxicity, repeated dose toxicity), both UN-GHS and EU-GHS (CLP) are using as guidance values for the 28 days oral chronic toxicity test a cut-off value of 300 mg/kg bw (daily gavage) as observed effect level. Since the single observed irreversible health effect, the calcium blood level in males, occured at a higher dose only, GHS classification does not apply for chronic oral toxicity of CA 2342 A. This is also supported by section 3.9.2.8 in the GHS and CLP documents, where it is stated that small changes in blood chemistry would not justify classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
